Literature DB >> 7549802

Cancer incidence in Thailand, 1988-1991.

V Vatanasapt1, N Martin, H Sriplung, K Chindavijak, S Sontipong, H Sriamporn, D M Parkin, J Ferlay.   

Abstract

Results from three cancer registries (Chiang Mai, Khon Kaen, and Songkhla) in different regions of Thailand and from a cancer survey in the population of Bangkok during the years 1988-1991 are presented, together with an estimate of the incidence of cancer for the country as a whole. Overall, liver cancer is the most frequent malignancy, but there are large regional differences in incidence and in histological type, with very high rates of cholangiocarcinoma in the northeast (associated with endemic opisthorchiasis) but a more even distribution of hepatocellular carcinoma. Lung cancer is second in frequency, with the highest rates in northern Thailand, where the incidence in women (Age Standardized Rate, 37.4 per 100,000) is among the highest in the world. A link with tobacco smoking is suggested by similarly raised rates, especially in women, for cancers of the larynx and pancreas. Cervical cancer is the most common malignancy in women, with relatively little regional variation in risk, while the incidence of breast cancer is low. Other cancer sites showing moderately increased rates include the lip and oral cavity, particularly in females from the north and northeast, where the chewing of betel nut remains common among older generations, nasopharyngeal cancer, carcinoma of the esophagus in the southern region, and penile cancer, especially in the north and northeast. Previous studies which have investigated the etiological factors underlying these patterns are reviewed, and the implications for future research and for national cancer control policies are discussed.

Entities:  

Mesh:

Year:  1995        PMID: 7549802

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  22 in total

1.  Immunohistochemical expression of mismatch repair genes: a screening tool for predicting mutator phenotype in liver fluke infection-associated intrahepatic cholangiocarcinoma.

Authors:  Upama Liengswangwong; Anant Karalak; Yukio Morishita; Masayuki Noguchi; Thiravud Khuhaprema; Petcharin Srivatanakul; Masanao Miwa
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

2.  Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma.

Authors:  Siobhan C McKay; Kristian Unger; Stephanos Pericleous; Gordon Stamp; Gerry Thomas; Robert R Hutchins; Duncan R C Spalding
Journal:  HPB (Oxford)       Date:  2011-03-10       Impact factor: 3.647

Review 3.  Environmental health in the biology century: Transitions from population to personalized prevention.

Authors:  John D Groopman
Journal:  Exp Biol Med (Maywood)       Date:  2019-03-20

4.  Anti-inflammatory effect of prednisolone on the growth of human liver fluke in experimental opisthorchiasis.

Authors:  Amornrat Juasook; Thidarut Boonmars; Sasithorn Kaewkes; Watcharin Loilome; Kulathida Veteewuthacharn; Zhiliang Wu; Puangrat Yongvanit
Journal:  Parasitol Res       Date:  2011-12-21       Impact factor: 2.289

5.  Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines.

Authors:  Nisana Tepsiri; Liengchai Chaturat; Banchob Sripa; Wises Namwat; Sopit Wongkham; Vajarabhongsa Bhudhisawasdi; Wichittra Tassaneeyakul
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

Review 6.  Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review.

Authors:  Gerald N Wogan; Thomas W Kensler; John D Groopman
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2011-06-01

Review 7.  Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology.

Authors:  Thomas W Kensler; Bill D Roebuck; Gerald N Wogan; John D Groopman
Journal:  Toxicol Sci       Date:  2010-09-29       Impact factor: 4.849

8.  Prognostic significance of microsatellite alterations at 1p36 in cholangiocarcinoma.

Authors:  Temduang Limpaiboon; Sumonta Tapdara; Patcharee Jearanaikoon; Banchob Sripa; Vajarabhongsa Bhudhisawasdi
Journal:  World J Gastroenterol       Date:  2006-07-21       Impact factor: 5.742

Review 9.  Cholangiocarcinoma: lessons from Thailand.

Authors:  Banchob Sripa; Chawalit Pairojkul
Journal:  Curr Opin Gastroenterol       Date:  2008-05       Impact factor: 3.287

10.  Exome sequencing of liver fluke-associated cholangiocarcinoma.

Authors:  Choon Kiat Ong; Chutima Subimerb; Chawalit Pairojkul; Sopit Wongkham; Ioana Cutcutache; Willie Yu; John R McPherson; George E Allen; Cedric Chuan Young Ng; Bernice Huimin Wong; Swe Swe Myint; Vikneswari Rajasegaran; Hong Lee Heng; Anna Gan; Zhi Jiang Zang; Yingting Wu; Jeanie Wu; Ming Hui Lee; DaChuan Huang; Pauline Ong; Waraporn Chan-on; Yun Cao; Chao-Nan Qian; Kiat Hon Lim; Aikseng Ooi; Karl Dykema; Kyle Furge; Veerapol Kukongviriyapan; Banchob Sripa; Chaisiri Wongkham; Puangrat Yongvanit; P Andrew Futreal; Vajarabhongsa Bhudhisawasdi; Steve Rozen; Patrick Tan; Bin Tean Teh
Journal:  Nat Genet       Date:  2012-05-06       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.